| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Quanterix Corp | 56% | -0.54% | $37,895,155 | +$3,529,782 | 30,560,609 | +10% | Quanterix Corporation | 28 Apr 2025 |
As of 30 Sep 2025, 0 institutional investors reported holding 0 shares of Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share (AKYA). This represents 0% of the company’s total 54,965,124 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 0 | $0 | -$16,297,787 | $1.29 | 0 |
| 2025 Q2 | 12,538,172 | $16,299,458 | +$393,896 | $1.30 | 57 |
| 2025 Q1 | 12,180,731 | $16,933,111 | -$396,201 | $1.39 | 64 |
| 2024 Q4 | 12,134,199 | $27,787,145 | -$94,785 | $2.29 | 60 |
| 2024 Q3 | 12,090,894 | $32,886,304 | -$635,710 | $2.72 | 59 |
| 2024 Q2 | 12,384,936 | $28,979,102 | -$9,288,103 | $2.34 | 59 |
| 2024 Q1 | 14,854,113 | $69,665,229 | +$406,816 | $4.69 | 67 |
| 2023 Q4 | 14,738,704 | $72,059,963 | -$6,427,619 | $4.88 | 61 |
| 2023 Q3 | 16,045,762 | $74,613,884 | -$6,821,099 | $4.65 | 60 |
| 2023 Q2 | 16,061,952 | $118,696,445 | +$17,919,105 | $7.39 | 72 |
| 2023 Q1 | 13,357,367 | $109,090,871 | -$6,745,364 | $8.18 | 63 |
| 2022 Q4 | 14,068,910 | $134,634,338 | -$3,382,215 | $9.57 | 71 |
| 2022 Q3 | 14,337,931 | $168,474,351 | +$16,264,570 | $11.75 | 54 |
| 2022 Q2 | 12,982,721 | $166,825,000 | +$9,078,038 | $12.85 | 53 |
| 2022 Q1 | 12,312,165 | $135,320,000 | -$259,038 | $10.99 | 45 |
| 2021 Q4 | 12,136,619 | $189,431,000 | +$26,496,438 | $15.31 | 44 |
| 2021 Q3 | 9,884,549 | $137,986,289 | -$15,851,344 | $13.96 | 46 |
| 2021 Q2 | 10,064,753 | $194,653,000 | +$194,652,901 | $19.34 | 60 |